Legal chiefs at pharmaceutical companies working on potential treatments for the coronavirus were among some of the highest-paid in the U.S. last year, according to a Bloomberg Law examination of 2019 proxy statements filed in recent weeks.
Amneal Pharmaceuticals Inc., a Bridgewater Township, N.J.-based company that makes the anti-malarial drug hydroxychloroquine, which received emergency authorization Monday from the Food and Drug Administration to treat those suffering from Covid-19, gave a compensation package worth more than $3.65 million last year to its now former chief legal officer David Buchen.
Buchen officially stepped down Feb. 3 from his role as chief legal ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.